Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)

被引：0

作者：

Luisa Klotz

Berit Grützke

Maria Eveslage

Michael Deppe

Catharina C. Gross

Lucienne Kirstein

Anita Posevitz-Fejfar

Tilman Schneider-Hohendorf

Nicholas Schwab

Sven G. Meuth

Heinz Wiendl

机构：

[1] University Hospital Münster,Department of neurology

[2] Westfaelische Wilhelms-University Münster,Institute of biostatistics and clinical research

来源：

BMC Neurology | / 15卷

关键词：

Multiple sclerosis; Natalizumab; Fingolimod; PML; Switching;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis [J].

Escribano, Begona M. ;

Aguilar-Luque, Macarena ;

Bahamonde, Carmen ;

Conde, Cristina ;

Lillo, Rafael ;

Sanchez-Lopez, Fernando ;

Giraldo, Ana I. ;

Cruz, Antonio H. ;

Luque, Evelio ;

Gascon, Felix ;

Aguera, Eduardo ;

Tunez, Isaac .

CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) :4876-4880

[42] Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study [J].

Baldi, Eleonora ;

Guareschi, Angelica ;

Vitetta, Francesca ;

Senesi, Caterina ;

Curti, Erica ;

Montepietra, Sara ;

Simone, Anna Maria ;

Immovilli, Paolo ;

Caniatti, Luisa ;

Tola, Maria Rosaria ;

Pesci, Ilaria ;

Montanari, Enrico ;

Sola, Patrizia ;

Granella, Franco ;

Motti, Luisa ;

Ferraro, Diana .

CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (09) :1849-1855

[43] Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal [J].

Rollot, Fabien ;

Couturier, Justine ;

Casey, Romain ;

Wiertlewski, Sandrine ;

Debouverie, Marc ;

Pelletier, Jean ;

De Seze, Jerome ;

Labauge, Pierre ;

Ruet, Aurelie ;

Thouvenot, Eric ;

Ciron, Jonathan ;

Berger, Eric ;

Gout, Olivier ;

Clavelou, Pierre ;

Stankoff, Bruno ;

Casez, Olivier ;

Bourre, Bertrand ;

Zephir, Helene ;

Moreau, Thibault ;

Lebrun-Frenay, Christine ;

Maillart, Elisabeth ;

Edan, Gilles ;

Neau, Jean-Philippe ;

Montcuquet, Alexis ;

Cabre, Philippe ;

Camdessanche, Jean-Philippe ;

Defer, Gilles ;

Ben Nasr, Haifa ;

Maurousset, Aude ;

Hankiewicz, Karolina ;

Pottier, Corinne ;

Leray, Emmanuelle ;

Vukusic, Sandra ;

Laplaud, David-Axel .

NEUROTHERAPEUTICS, 2022, 19 (02) :476-490

[44] No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab [J].

Johnsson, Magnus ;

Farman, Helen H. ;

Blennow, Kaj ;

Zetterberg, Henrik ;

Malmestrom, Clas ;

Axelsson, Markus ;

Lycke, Jan .

MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (13) :2070-2080

[45] A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK [J].

Montgomery, Stephen M. ;

Maruszczak, Maciej J. ;

Slater, David ;

Kusel, Jeanette ;

Nicholas, Richard ;

Adlard, Nicholas .

JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (05) :474-482

[46] Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes [J].

Yano, Hajime ;

Gonzalez, Cindy ;

Healy, Brian C. ;

Glanz, Bonnie, I ;

Weiner, Howard L. ;

Chitnis, Tanuja .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 :119-127

[47] Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" study [J].

Filippi, Massimo ;

Pagani, Elisabetta ;

Turrini, Renato ;

Bartezaghi, Marta ;

Morra, Vincenzo Brescia ;

Borriello, Giovanna ;

Clerici, Valentina Torri ;

Mirabella, Massimiliano ;

Pasquali, Livia ;

Patti, Francesco ;

Totaro, Rocco ;

Gallo, Paolo ;

Rocca, Maria A. .

JOURNAL OF NEUROLOGY, 2024, :6181-6196

[48] Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis [J].

Walczak, Agata ;

Kurkowska-Jastrzebska, Iwona ;

Zakrzewska-Pniewska, Beata ;

Dorobek, Malgorzata ;

Brola, Waldemar ;

Zajdel, Radoslaw ;

Bartosik-Psujek, Halina ;

Stasiolek, Mariusz ;

Kulakowska, Alma ;

Rusek, Stanislaw ;

Tutaj, Andrzej ;

Glabinski, Andrzej ;

Wlodek, Agata ;

Kochanowski, Jan ;

Ciach, Agnieszka ;

Siger, Malgorzata ;

Kurowska, Katarzyna ;

Wicha, Wojciech ;

Nojszewska, Monika ;

Podlecka-Pietowska, Aleksandra ;

Czajka, Anna ;

Kapica-Topczewska, Katarzyna ;

Bielecki, Bartosz ;

Maciagowska-Terela, Marzena ;

Stepien, Adam .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 184

[49] Index of cardiac-electrophysiological balance in relapsing-remitting multiple sclerosis patients treated with fingolimod [J].

Gunay-Polatkan, S. ;

Gullu, G. ;

Sigirli, D. ;

Koc, E. R. ;

Aydinlar, A. ;

Turan, O. F. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 76

[50] Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients [J].

Cannizzaro, Miryam ;

Ferre, Laura ;

Clarelli, Ferdinando ;

Giordano, Antonino ;

Sangalli, Francesca ;

Colombo, Bruno ;

Comi, Giancarlo ;

Moiola, Lucia ;

Martinelli, Vittorio ;

Filippi, Massimo ;

Esposito, Federica .

JOURNAL OF NEUROLOGY, 2022, 269 (10) :5596-5605

← 1 2 3 4 5 →